Evidence map›Paper›PMID 38553804›Full record

ArticleWomen's health (London, England)

Maternal mortality and COVID-19: A nationwide ecological analysis from Ecuador.

Esteban Ortiz-Prado, Juan S Izquierdo-Condoy, Raúl Fernández-Naranjo, Jorge Vásconez-González, Nathaly Izquierdo-Condoy, Diana Checa-Jaramillo, Pablo Yanchapaxi-Silva, Tatiana Asmal-Iturralde, María Gabriela Dávila Rosero, Sarah J Carrington and 1 more

Open access · goldAbstract read
In one paragraph

Article in Women's health (London, England). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Esteban Ortiz-PradoOne Health Research Group, Faculty of Medicine, Universidad de las Americas, Quito, Ecuador.ORCID 0000-0002-1895-7498
Juan S Izquierdo-CondoyOne Health Research Group, Faculty of Medicine, Universidad de las Americas, Quito, Ecuador.ORCID 0000-0002-1178-0546
Raúl Fernández-NaranjoOne Health Research Group, Faculty of Medicine, Universidad de las Americas, Quito, Ecuador.
Jorge Vásconez-GonzálezOne Health Research Group, Faculty of Medicine, Universidad de las Americas, Quito, Ecuador.
Nathaly Izquierdo-CondoyGynecology and Obstetrics Service, Hospital Luis Gabriel Dávila, Tulcan, Ecuador.
Diana Checa-JaramilloOne Health Research Group, Faculty of Medicine, Universidad de las Americas, Quito, Ecuador.
Pablo Yanchapaxi-SilvaOne Health Research Group, Faculty of Medicine, Universidad de las Americas, Quito, Ecuador.
Tatiana Asmal-IturraldeOne Health Research Group, Faculty of Medicine, Universidad de las Americas, Quito, Ecuador.ORCID 0000-0003-4958-3262
María Gabriela Dávila RoseroOne Health Research Group, Faculty of Medicine, Universidad de las Americas, Quito, Ecuador.
Sarah J CarringtonOne Health Research Group, Faculty of Medicine, Universidad de las Americas, Quito, Ecuador.
Hugo Sanchez-SanMiguelGynecology and Obstetrics Service, Hospital Axxis, Quito, Ecuador.
Universidad de Las Américas · ECHospital Luis Vernaza · ECHospital Vozandes · EC

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDuring the COVID-19 pandemic, distinct population subsets, including pregnant women, have been differentially affected. While over 90% of COVID-19-infected pregnant women experience a benign course, a subset demonstrates marked clinical exacerbation. Symptomatic pregnant individuals, in particular, present a heightened risk of severe disease in comparison to their non-pregnant counterparts.

objectiveThe objective of this study is to systematically evaluate the epidemiological characteristics of COVID-19 in pregnant women, assess related maternal mortalities, ascertain the case fatality rate, and delineate associated risk factors.

designThis is a comprehensive population-based ecological study. METHODOLOGY: A population-based study was conducted to investigate the epidemiological patterns of COVID-19-associated morbidity and mortality in pregnant women in Ecuador from 27 February 2020 to 14 May 2021.

resultsA total of 3274 positive COVID-19 cases were identified among pregnant women, with 22 official fatalities, yielding a case fatality rate of 0.67%. The majority of cases were of Mestizo ethnicity (92.66%); however, the highest case fatality rate was noted among indigenous pregnant women (case fatality rate = 1.25%), those aged between 40 and 44 years (case fatality rate = 2.68%), and those with a history of comorbidities (2.08%). Pregnant women residing at lower altitudes (<2500 m) exhibited a higher incidence rate (0.20/100,000) compared to those at higher altitudes (>2500 m), which stood at 0.17/100,000.

conclusionThe COVID-19 pandemic has profoundly impacted pregnant women in Ecuador during the first 14 months, particularly those with comorbidities, older age, and of indigenous ethnicity. These factors have heightened their vulnerability and susceptibility to severe COVID-19 infection and subsequent mortality. This underscores the urgency for comprehensive protective measures, including prioritization for vaccination. Further studies are needed to inform tailored prevention strategies and therapeutic interventions for these high-risk groups.

Indexed as

COVID-19Pregnancy Complications, InfectiousAdultEcuadorFemaleHumansMaternal MortalityPandemicsPregnancySARS-CoV-2COVID-19epidemiologypregnancypregnant womenSARS-CoV-2

Identifiers

PMID38553804
PMCPMC10981214
OpenAlexW4393347082

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.